Profiel
Florence Alouch is the founder and former Chief Executive Officer of SparingVision SAS, which was founded in 2016.
Currently, she is the Chairman-Supervisory Board at Génomic Vision SA since 2022.
Ms. Alouch holds an MBA from École des Hautes Études Commerciales de Paris and a graduate degree from Universite Paris Cite.
Actieve functies van Florence Alouch
Bedrijven | Functie | Begin |
---|---|---|
GENOMIC VISION | Chairman | 11-07-2022 |
Eerdere bekende functies van Florence Alouch
Bedrijven | Functie | Einde |
---|---|---|
SparingVision SAS
SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | Chief Executive Officer | - |
Opleiding van Florence Alouch
École des Hautes Études Commerciales de Paris | Masters Business Admin |
Universite Paris Cite | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
GENOMIC VISION | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
SparingVision SAS
SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | Health Technology |